Tsai Philip, Chief Technical Officer at Immunome Inc. ($IMNM), made two open market purchases of company shares in the last year, totaling over $308,000. His most recent buy occurred on December 19, 2025. Among nearly 5,000 insiders tracking open market buys, his activity ranks 1,118th by dollar amount, compared to an average of about $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Tsai Philip | Chief Technical Officer | P | Common Stock | 10000 | $20.49 | 43,300.0000 | 91,710,277 | 30.03% | 0.01% |
| July 29, 2025 | Immunome Inc. | $IMNM | Tsai Philip | Chief Technical Officer | A | Employee Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2025 | Immunome Inc. | $IMNM | Tsai Philip | Chief Technology Officer | P | Common Stock | 12300 | $8.42 | 33,300.0000 | 0 | 58.57% | 0.00% |
| Nov. 21, 2024 | Immunome Inc. | $IMNM | Tsai Philip | Chief Technology Officer | P | Common Stock | 21000 | $9.43 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Immunome Inc. | $IMNM | Tsai Philip | Chief Technology Officer | A | Stock option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |